UAE pharmaceutical market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of expanding healthcare industry and investment in the industry. Surging demands from the growing population of the country for efficient pharmaceutical products are further driving the growth of the UAE pharmaceutical market in the upcoming five years.

Government Initiatives Drive Market Growth

United Arab Emirates’ government is actively focused on advancing the pharmaceutical industry. Initiatives like the Dubai Industrial Strategy 2030 and the Abu Dhabi vision 2030 is focused toward developing the pharmaceutical industry due to its future growth prospects, export potential and mid-term to long-term economic impact. Till recent past, the country pharmaceutical demands were highly met through imported drugs and pharmaceutical products. Going forward, the country is actively functioning to decrease the import of pharmaceutical and manufacture their own products through increasing investments in pharmaceutical and therapeutic products’ research and development.

In the year 2018, country imported pharmaceutical products worth over USD14.9 billion from the countries like Germany, USA, France and Switzerland. To increase their self-production of pharmaceutical products the country is initiating bonds with multinational market players. With favorable schemes and plans for the distribution channels and funding strategic location and sophisticated logistics infrastructure is also anticipated to further strengthen the growth of the UAE pharmaceutical market in the future five years.

India – UAE Bilateral Trade Supports Pharmaceutical Industry

India stands 3rd in terms of pharmaceutical products volume production and 14th in terms of value of the industry across the world. With the historic partnership, the countries are trying to establish a conjugated pharmaceutical industry that would benefit the industry in both countries. Moreover, with the recent pandemic effect the import-export channels have suffered drastically in recent years. Therefore, UAE is trying to establish more permanent solution to the surging demands for the pharmaceutical products in the country.

Growing Instances Of Diseases Upsurges Drug Demands

Increasing number of chronic diseases, infectious diseases, and lifestyle diseases are major factor influencing the growth of the pharmaceutical market in the country. Chronic diseases like cardiovascular diseases, cancer, neurological disorders, etc. are driving the market growth. 4,807 new cancer cases were observed in the country among both male and female population in the country.

Infectious diseases due to higher tourism, and environmental factor, and the recent viral infection due to COVID-19 facilitated the demand for pharmaceutical products. Disrupted import channels, have pushed the pharmaceutical companies in the country to manufacture drugs and medicines in the country and government also supported the notion with higher investment in the sector.

Click here to download the sample

Market Segmentation

The UAE pharmaceutical market is segmented by drug type, product type, application, distribution channel, competitional landscape, and regional distribution. Based on drug type, the market is differentiated between generic drugs and branded drugs. Product type based market segment is divided between prescription drugs and over the counter drugs.

Application based market segment is further fragmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Based on distribution channel, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Dubai region, Sharjah region, Abu Dhabi region and the rest of the UAE. 

Company Profile

Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC, among others is a partial list of major market players of the companies responsible for the growth of UAE pharmaceutical market.



Base Year


Historical Data

2017 – 2020

Estimated Year


Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Drug Type

·         Product Type

·         Application

·         Distribution Channel

Regional scope

Northern region, Central region, and Southern region.

Key companies profiled

Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, UAE pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • UAE Pharmaceutical Market, By Drug Type:
    • Generic Drugs
    • Branded Drugs
  • UAE Pharmaceutical Market, By Product Type:
    • Prescription Drugs
    • Over-The-Counter Drugs
  • UAE Pharmaceutical Market, By Application:
    • Cardiovascular
    • Musculoskeletal
    • Oncology
    • Anti-infective
    • Metabolic Disorder
    • Others
  • UAE Pharmaceutical Market, By Distribution Channel:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • UAE Pharmaceutical Market, By Region:

o   Dubai Region

o   Sharjah Region

o   Abu Dhabi Region

o   Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE pharmaceutical market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
UAE Pharmaceutical Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on UAE Pharmaceutical Market

4.    Executive Summary

5.    Voice of Customer

6.    UAE Pharmaceutical Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Type (Generic Drugs v/s Branded Drugs)

6.2.2.     By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

6.2.3.     By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    UAE Generic Drugs Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product Type

7.2.2.     By Application

7.2.3.     By Distribution Channel

8.    UAE Branded Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product Type

8.2.2.     By Application

8.2.3.     By Distribution Channel

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  UAE Economic Profile

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Company Profiles

13.2.1.  Julphar Gulf Pharmaceutical Industries

13.2.2.  Bayer Consumer Health

13.2.3.  Lifepharma FZE

13.2.4.  Niner Pharmaceuticals LLC

13.2.5.  GlaxoSmithKline & Neopharma

13.2.6.  Pfizer UAE

13.2.7.  Johnson & Johnson Middle East FZ-LLC

14.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]